La. Public Health and Safety § 40:1168.2

Current with changes from the 2024 legislative session effective on or before 7/1/2024, from Acts 1-3, 6-671

Section 40:1168.2 - Definitions

For purposes of this Subpart, the following terms have the meaning ascribed to them in this Section:

(1) "Adverse event" means any incident relating to the use of a drug prescribed or recommended to a patient that may result in serious harm or injury to the patient or in the patient's death.

(2) "Authorized clinician" means all of the following licensed health professionals authorized pursuant to R.S. 40:1046 to recommend medical marijuana to patients:

(a) Any physician licensed by and in good standing with the Louisiana State Board of Medical Examiners to practice medicine in this state.

(b) Any nurse practitioner licensed by and in good standing with the Louisiana State Board of Nursing to practice advanced practice registered nursing in this state and who has prescriptive authority conferred by the Louisiana State Board of Nursing.

(c) Any medical psychologist licensed by and in good standing with the Louisiana State Board of Medical Examiners to practice medical psychology in this state.

(3) "Board" means the Louisiana State Board of Medical Examiners.

(4) "Data system" means the system authorized and provided for in R.S. 40:1168.3.

(5) "Medical marijuana" means the therapeutic substance produced under the authority of and in accordance with R.S. 40:1046.

La. Public Health and Safety § 40:1168.2

Acts 2019, No. 207, §1; Acts 2022, No. 444, §1.

Amended by Acts 2022, No. 444,s. 1, eff. 8/1/2022.

Added by Acts 2019, No. 207,s. 1, eff. 8/1/2019.